Medicine Quality Alert: Class II Recall of Izzi Three (Azithromycin 200mg/5ml) Suspension, Batch Number BPL 539 A
The Pharmacy and Poisons Board has mandated the recall of Izzi Three (Azithromycin Oral Suspension B.P. equivalent to Azithromycin anhydrous 200mg), Batch Number BPL 539A, manufactured by Biopharma Limited, due to failure to comply with the specifications of physical appearance.
From: Pharmacy and Poisons Board
Date of Recall Initiation: 20/08/2025
Recall Reference Number: REC/2025/026
Recall Classification: Class II
Recall Level: Retail/Facility level
Manufacturer: Biopharma Ltd
Product name: Izzi Three
Active Pharmaceutical Ingredient: Azithromycin Oral Suspension B.P. equivalent to Azithromycin anhydrous 200mg
Affected counties: All
Affected Batch
Batch Number | Date of Manufacture | Date of expiry | Pack Size |
BPL 539A | 11/2023 | 10/2026 | 15ml |
Brief description of the problem
The product is being recalled due to failure to comply with the specifications of physical appearance, whereby an off-white to light yellow viscous mobile homogenous suspension was observed against the specification of an orange, viscous mobile homogenous suspension. The product had been sampled following a risk-based post-market surveillance.
Action for healthcare professionals
Stop supplying the above batches immediately. Quarantine all remaining stock and await contact from Biopharma Limited, Kenya, who will contact healthcare professionals directly to arrange the return.
Action for patients and carers
No further action is required by patients as this is a Retail/hospital Pharmacy and Wholesaler/Distributor level recall. You are advised to talk to your healthcare professional if you have the above batch of Izzithree oral suspension.
Further Information
For inquiries about consignments of the impacted batch, please contact Biopharma Limited by email at: info@biopharmaltd.com Tel: +254 717768794
You are advised to promptly report any case(s) of adverse events and suspected substandard and falsified products to the nearest healthcare facility or through the following channels:
- https://pv.pharmacyboardkenya.org/users/mpublic
- USSD code at *271#
- Email pv@ppb.go.ke or pms@ppb.go.ke
- Telephone No. 0795743049
- Mobile application: mPvERS both Android and iOS
For any further enquiries and feedback on the product recall, contact the post-marketing surveillance unit at the Pharmacy and Poisons Board via email at pms@ppb.go.ke
Download document
Medicine Quality Alert: Class II Medicine Recall Izzi Three (Azithromycin Oral Suspension B.P. equivalent to Azithromycin anhydrous 200mg) Batch Number BPL. 539 A.